Bioatla Inc reports results for the quarter ended in March - Earnings Summary

Bioatla

14/05/2024 23:42

* Bioatla Inc  BCAB.OQ  reported a quarterly adjusted loss
of 48
cents​​ per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of -58
cents.  The mean expectation of five analysts for the quarter
was for a loss of 54 cents per share. Wall Street expected
results to range from -60 cents to -44 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Bioatla Inc's reported EPS for the quarter was a loss
of 48
cents​.
    * The company reported a quarterly loss of $23.23 million.
    * Bioatla Inc shares had fallen by 23.3% this quarter and
gained 7.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 16.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Bioatla Inc is
$12.50 
This summary was machine generated from LSEG data May 14 at
10:41 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.54          -0.48          Beat
 Dec. 31 2023      -0.79                         
 Sep. 30 2023      -0.80          -0.70          Beat
 Jun. 30 2023      -0.64          -0.75          Missed